Clinical trial
Early Prediction and Diagnosis of CSA-AKI
NCT07811570 is registered in ClinicalTrials.gov with China National Center for Cardiovascular Diseases as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Early Prediction and Diagnosis of CSA-AKI
- Lead sponsor
- China National Center for Cardiovascular Diseases
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- March 1, 2026
- Completion date
- June 30, 2027
- Enrollment
- 1,500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute kidney injury, biomarkers, cardiovascular surgery, csa-aki